Complimentary CE Webinar on HER2-expressing Solid Tumors - Friday, May 30th
Webinar/Online
Friday, May 30, 2025 at 6:30pm CT - 8:00pm CT
This event has ended.
Info
Topic
Solid Tumors
Credits Offered
This event offers
1.5 contact hours
to attendees.
Accreditation Info:
Med Learning Group.
Additional Information
The goal of this program is to increase the health care professional’s ability to: analyze clinical data with use of HER2-targeted antibody-drug conjugates in HER2-expressing solid tumors and identify potential adverse events.
Speakers
Bradley Monk
MD, FACS, FACOG
Medical Director
Late-Phase Clinical Research
Florida Cancer Specialists and Research Institute
West Palm Beach, FL